Early-Stage Rectal Cancer
Cross-source consensus on Early-Stage Rectal Cancer from 1 sources and 4 claims.
1 sources · 4 claims
Background
Other
Highlighted claims
- Eligible patients must have biopsy-proven rectal adenocarcinoma staged cT1-3ab, N0 or limited N1, M0/Mx. — Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study
- Eligible tumours must be 40 mm or smaller on MRI and located in the distal or mid rectum without anal canal involvement. — Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study
- Screening programmes and improved imaging have increased detection of early-stage rectal cancers, raising the need for broader organ-preserving strategies. — Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study
- Patients with threatened mesorectal fascia, mucinous tumour on MRI, definite distant metastases, or prior pelvic radiotherapy are excluded. — Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study